KemPharm is a Florida-based biopharmaceutical company that researches and develops novel molecule therapies to treat CNS, neurodegenerative and lysosomal storage disorders.
Business Model:
Revenue: $10.7M
Employees: 11-50
Address: 1180 Celebration Boulevard
City: Celebration
State: FL
Zip: 34747
Country: US
KemPharm is a Florida-based biopharmaceutical company that researches and develops novel molecule therapies to treat CNS, neurodegenerative and lysosomal storage disorders.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/1/2015
Ticker Symbol:
KMPH
IPO Price:
$12/share
Amount Raised:
$64M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2008 | Series A | 1 | $647k |
BP Growth Partners BP Growth Partners BP Growth Partners BP Growth Partners |
3/2015 | Venture Round | $4M | 6/2021 | Private Placement | $39.1M | 4/2020 | Debt | $350k |
U.S. Small Business Administration. |
12/2019 | Post-IPO Equity | $71M | 1/2021 | Post-IPO Equity | $50M | 8/2009 | Series B | 1 | $3.5M |
BP Growth Partners BP Growth Partners BP Growth Partners BP Growth Partners |
1/2021 | Post-IPO Equity | $31.5M | 5/2013 | Debt Financing | $762k | 6/2014 | Debt Financing | 1 | $60M |
Deerfield Deerfield |
7/2010 | Venture Round | $6.9M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|